A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...
The Onagawa unit cleared safety screening in February 2020 under stricter safety standards set after the 2011 nuclear ...
Japan's nuclear watchdog on Wednesday formally disqualified a reactor in the country's north-central region from restarting, ...
AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback